Screener
SI-BONE, Inc. SIBN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by SI-BONE, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001459839-26-000056
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Effect of exchange rate changes on cash and cash equivalents | (145) | 417 |
| Net increase (decrease) in cash and cash equivalents | (8,705) | 6,239 |
| Cash and cash equivalents at | ||
| Beginning of period | 42,240 | 34,948 |
| End of period | $33,535 | $41,187 |
| Supplemental disclosure of non-cash information | ||
| Unpaid purchases of property and equipment | $525 | $815 |
| Right-of-use asset obtained in exchange for a lease liability | $6,579 | — |
Item 1. Financial Statements
FAQ
- What is SI-BONE, Inc.'s cash & equivalents?
- SI-BONE, Inc. (SIBN) reported cash & equivalents of $33.54M in Q1 2026.
- How has SI-BONE, Inc.'s cash & equivalents changed year-over-year?
- SI-BONE, Inc.'s cash & equivalents decreased by 18.6% year-over-year, from $41.19M to $33.54M.
- What is the long-term trend for SI-BONE, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), SI-BONE, Inc.'s cash & equivalents has grown at a -4.6% compound annual growth rate (CAGR), from $53.58M to $42.24M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about SI-BONE, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude